← Back to Patent Explorer
US4280996A Expired / Lapsed US ⏱️ 0.0 years remaining

Fat emulsion for intravenous injection

Assignee: Tanabe Pharma Corp
•
Filing: 1979-09-13
•
Granted: 1981-07-28
•
Expires: 1999-09-13
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A stable fat emulsion having low side effects, which is suitable as nutritive infusion fluid for intravenous injection, is provided. The emulsion contains 5-50 (W/V) % of soybean oil, yolk phospholipids in a weight ratio to the soybean oil of 1/4-1/25, 0.01-0.30 (W/V) % of a fatty acid or salt thereof having 12-20 carbon atoms and the balance of water.

Inventors

  • 👤 Hiroyuki Okamoto
  • 👤 Yoshio Tsuda
  • 👤 Kazumasa Yokoyama

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-03 13:44
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0019; A61K9/0029; A61K31/00; A61K31/66; A61K31/683; A61K31/685; A61K36/00; A61K36/18; A61K36/185; A61K36/48; A61P; A61P3/00; A61P3/06

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 74 words
A fat emulsion suitable for intravenous injection comprising 5 to 50 (w/v)% of soybean oil, yolk phospholipids in a weight ratio of the soybean oil of 1/4 to 1/25, glycerol or glucose as an isotonic agent, the diameter of the emulsified particles being 0.1μ or less, water, 0.01 to 0.30 (w/v)% of a fatty acid having 12 to 20 carbon atoms or a pharmaceutically acceptable salt thereof and 0.005 to 0.50 (w/v)% of cholesterol.
Claim 2
Dependent Claim 74 words
A fat emulsion suitable for intravenous injection comprising 5 to 50 (w/v)% of soybean oil, yolk phospholipids in a weight ratio of the soybean oil of 1/4 to 1/25, glycerol or glucose as an isotonic agent, the diameter of the emulsified particles being 0.1μ or less, water, 0.01 to 0.30 (w/v)% of a fatty acid having 12 to 20 carbon atoms or a pharmaceutically acceptable salt thereof and 0.005 to 0.50 (w/v)% of cholesterol.
Claim 3
Dependent Claim 23 words
An emulsion according to claim 1, wherein the amount of the fatty acid or pharmaceutically acceptable salt thereof is 0.04 to 0.07 (W/V)%.
Claim 4
Dependent Claim 38 words
An emulsion according to 1 wherein the fatty acid is stearic acid, oleic acid, linoleic acid, palmitic acid or linolenic acid and the amount of the fatty acid or pharmaceutically acceptable salt thereof is 0.04 to 0.07 (w/v)%.
Claim 5
Dependent Claim 38 words
An emulsion according to 1 wherein the fatty acid is stearic acid, oleic acid, linoleic acid, palmitic acid or linolenic acid and the amount of the fatty acid or pharmaceutically acceptable salt thereof is 0.04 to 0.07 (w/v)%.
Claim 6
Dependent Claim 32 words
An emulsion according to claim 1 which is characterized by being sufficiently stable after storage at 4° C. for 24 months that the emulsified particles have a diameter of not over 0.11±0.03μ.

References Cited (Backward Citations)

CA615342A Cited
US1939166A Cited
US2185969A Cited
US3004892A Cited
CA725596A Cited
FR8014M Cited
US4089801A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-07-27 1985-01-26 1985-07-28 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-07-27 1989-01-26 1989-07-28 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-07-27 1993-01-26 1993-07-28 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag